logo
Select company
Select metric
Ticker Information

Ticker

MGNX

Company Name

MACROGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MACROGENICS INC - Price to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGNX - P/OCF Historical data
DateMarket CapitalizationNet Cash Flow - OperationsPrice to Operating Cash Flow
6/30/2025$ 102.39M$ -72.12M0
3/31/2025$ 97.16M$ -69.62M0
12/31/2024$ 132.49M$ -68.37M0
9/30/2024$ 236.62M$ -58M0
6/30/2024$ 228.31M$ -153.41M0
3/31/2024$ 918.83M$ -111.02M0
12/31/2023$ 1.28B$ -78.2M0
9/30/2023$ 337.44M$ -20.85M0
6/30/2023$ 308.51M$ 4.98M62
3/31/2023$ 444M$ -42.1M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MACROGENICS INC's latest trailing twelve months (TTM) P/OCF stands at 0.
  • Over the past 5 years, MACROGENICS INC's average P/OCF has been 62.
  • The median P/OCF for MACROGENICS INC during this period was 62
  • MACROGENICS INC reached its highest P/OCF over the past 5 years at 62.
  • The lowest P/OCF recorded by MACROGENICS INC in the same timeframe 62

MACROGENICS INC's P/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/OCF Benchmarks
CompanyP/OCF
CHRS : COHERUS ONCOLOGY INC -IGMS : IGM BIOSCIENCES INC -ATRA : ATARA BIOTHERAPEUTICS INC -STRO : SUTRO BIOPHARMA INC -AGEN : AGENUS INC -CELU : CELULARITY INC -CSBR : CHAMPIONS ONCOLOGY INC 14.91IVVD : INVIVYD INC -PLX : PROTALIX BIOTHERAPEUTICS INC -BDTX : BLACK DIAMOND THERAPEUTICS INC 7.26

Definition of Price to Operating Cash Flow

[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
Market Cap / CF - Operations
(=) P/OCF
P/OCF for MACROGENICS INC is calculated as follows: Market Cap [ $ 1.18B ] / CF - Operations [ $ -144.41M ]
(=) P/OCF [ 0 ]

MGNX - Price to Operating Cash Flow, Last 5 years

62

Minimum

Jun 30, 2023

62

Maximum

Jun 30, 2023

62

Average

62

Median

P/OCF Benchmark Analysis

The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.82.
The following table provides additional summary stats:
P/OCF in the Market:
filtered constituents2.56K
min0.08
max42.19
average13.1
median10.77
std8.82